Help with healthcare costs for hypertrophic cardiomyopathy
This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below. If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you.
Eligibility criteria
To be eligible for this fund, you must:
- Have a confirmed diagnosis and are in treatment for hypertrophic cardiomyopathy, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months. This includes active surveillance of a condition
- Have health insurance that covers your qualifying expenses
- Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
- Be a legal resident and receive treatment in the U.S. or a U.S. territory
- Be prescribed a medication or product listed in the approved medications, listed below
Quick eligibility checker
- Treatment
- Insurance
- Income
Approved medications
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
- Betapace (Sotalol)
- Blocadren (Timolol)
- Bumex (Bumetanide)
- Bystolic (Nebivolol)
- Calan (Verapamil)
- Camzyos (Mavacamten)
- Cardizem (Diltiazem)
- Corgard (Nadolol)
- COUMADIN (Warfarin)
- Eliquis (Apixaban)
- Inderal (Propranolol)
- Lasix (Furosemide)
- Lopressor (Metoprolol)
- Myqorzo (Aficamten)
- Norpace (Disopyramide)
- Pacerone (Amiodarone)
- Pradaxa (Dabigatran)
- Rythmol (Propafenone)
- Savaysa (Edoxaban)
- Soaanz (Torsemide)
- Tambocor (Flecainide)
- Tenormin (Atenolol)
- Tikosyn (Dofetilide)
- Xarelto (Rivaroxaban)
- Zebeta (Bisoprolol)
About the disease
Hypertrophic cardiomyopathy (HCM) is a genetic or acquired cardiac condition characterized by abnormal thickening of the heart muscle, most commonly involving the left ventricle, which may impair cardiac function. The disease includes both obstructive and non-obstructive forms and may be associated with left ventricular outflow tract obstruction, diastolic dysfunction, mitral valve abnormalities, and arrhythmias.
Diagnosis codes
I42.1, I42.2, Q24.8
How to apply
-
If your fund is open, apply online 24/7, or call 866-512-3861, Monday – Friday, 8:30am – 5:30pm ET.
-
Answer pre-screening questions to confirm eligibility. Have your income, medication, diagnosis, and insurance information ready.
-
Complete the application and get an instant approval decision. You can begin using your grant right away.
Application guides
Questions?
Search help articles
Find answers to your questions about applying, claims, grant use, and your portal account.
Search help
How does it work?
You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses.
Learn more
Need help applying?
Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Contact usRelated organizations
Connect with other organizations and resources for support.
Featured partner:
Mended Hearts® supports individuals living with cardiovascular disease, along with their caregivers and families, through peer-to-peer support and education. They raise awareness of the challenges faced by those with cardiovascular disease and advocate to improve quality of life at every stage of the journey.
Get support
Explore resources beyond TotalAssist
Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more. Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
Find resources